Table 1.
Baseline characteristics according to CCC
| Variables | Group 1 (n = 66) | Group 2 (n = 72) | p value |
|---|---|---|---|
| Age, years | 60 ± 9.2 | 59.6 ± 7.4 | 0.760 |
| Male, % | 52.6 | 61.7 | 0.285 |
| Diabetes, % | 35 | 16.7 | 0.013 |
| Hypertension | 38.3 | 20.5 | 0.021 |
| Smoking, % | 20.5 | 18.3 | 0.749 |
| Family history of CAD, % | 21.8 | 18.3 | 0.616 |
| Systolic BP, mm Hg | 152 ± 19 | 143 ± 15 | 0.001 |
| Diastolic BP, mm Hg | 84 ± 10 | 83 ± 14 | 0.833 |
| LVEF, % | 42.6 ± 7 | 48.1 ± 7.8 | <0.001 |
| WBC count, ×103/μl | 9.5 ± 3.7 | 9 ± 3.1 | 0.532 |
| Platelet count, ×103/μl | 255 ± 78 | 270 ± 88 | 0.339 |
| Mean platelet volume, fl | 8.1 ± 1.0 | 8.0 ± 1.2 | 0.821 |
| NLR | 4.5 ± 0.7 | 2.7 ± 0.6 | <0.001 |
| Blood glucose, mg/dl | 145 ± 64 | 149 ± 69 | 0.735 |
| eGFR, ml/min/1.73 m2 | 80.8 ± 6.5 | 89.9 ± 9.9 | <0.001 |
| LDL-cholesterol, mg/dl | 123 ± 29 | 120 ± 34 | 0.581 |
| HDL-cholesterol, mg/dl | 36 ± 9 | 37 ± 7 | 0.703 |
| Triglyceride, mg/dl | 155 ± 40 | 150 ± 48 | 0.123 |
| hs-CRP, mg/l | 4 ± 1.9 | 3 ± 1.3 | 0.001 |
| Previous medications | |||
| Aspirin | 26.9 | 35 | 0.307 |
| Statins | 23.1 | 21.7 | 0.844 |
| ACE inhibitors/ARB | 32.1 | 35 | 0.716 |
| Beta-blockers | 33.3 | 30 | 0.677 |
| Calcium-channel blockers | 25.6 | 18.3 | 0.308 |
| Multivessel disease | 50 | 46.7 | 0.698 |
ACE = Angiotensin-converting enzyme; ARB = angiotensin receptor blocker; CAD = coronary artery disease; HDL = high-density lipoprotein; LDL = low-density lipoprotein; WBC = white blood cell.